Legal Representation
Attorney
Jill Anderfuren
USPTO Deadlines
Application History
37 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 25, 2025 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Oct 28, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 28, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 22, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 25, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 17, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 17, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 17, 2025 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 11, 2025 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Sep 11, 2025 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| Sep 11, 2025 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Sep 11, 2025 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Sep 7, 2025 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Mar 6, 2025 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Mar 6, 2025 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Mar 6, 2025 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Mar 4, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 4, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 4, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 4, 2025 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Mar 4, 2025 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Mar 4, 2025 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Dec 3, 2024 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| Dec 3, 2024 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Dec 3, 2024 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Jan 19, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jan 19, 2024 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jan 19, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jan 17, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 16, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 16, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 8, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 8, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 8, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 7, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 28, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 13, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for the prevention and treatment of cancer and infectious diseases; therapeutic pharmaceuticals for the prevention and treatment of cancer and infectious diseases; immunopharmaceuticals for the prevention and treatment of cancer and infectious diseases; vaccines; therapeutic vaccines; multispecific antibodies for medical therapeutic purposes; multi-specific immunotherapeutic pharmaceutical compositions for the prevention and treatment of cancer and infectious diseases
Class 042
Medical research; Research and development of pharmaceuticals; research and development services in the field of antibodies, and immunotherapies for the treatment of cancer and infectious diseases; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; pharmaceutical research and development; vaccine research and development services; research and development in the field of immunotherapy
Classification
International Classes
005
042